The Global Micro Balloon Catheter Market is forecasted to be appraised at US$ 416 million by 2032, up from US$ 286 million in 2022, advancing at a CAGR of 3.4% during the forecast period.
Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5860
The micro balloon catheter is a novel medical device that consists of a guidewire and a catheter. To treat constricted blood vessels, it is inserted into the femoral artery in the leg or, in some cases, the radial artery in the arm.
The growing prevalence of cardiovascular diseases is driving up demand for micro balloon catheters. The micro balloon catheters also include minimally invasive procedures for opening blocked or narrowed coronary arteries caused by coronary artery disease (CAD), which boosts micro balloon catheter sales.
The micro balloons catheter market is expected to grow significantly during the forecast period due to an increase in the prevention of heart attacks and angina in patients with coronary artery diseases.
What are the Key Driving and Restraining Factors in the Micro Balloon Catheters Market?
The rising prevalence of cardiac diseases and the growing geriatric population are the major factors driving the growth of the micro balloon catheter market. Globally, the number of cardiology intervention procedures is increasing, which is driving up demand for micro balloon catheters.
Furthermore, the rise of interventional cardiology has facilitated the use of micro balloon catheters, and there is an increase in the prevalence of patients suffering from end-stage renal disease, which is driving up sales of micro balloon catheters.
In addition, the number of patients seeking renal replacement therapy has grown. Catheter device manufacturers are developing efficient and cost-effective solutions. These incidents are expected to have an impact on the growth of the micro balloon catheter market in the coming years.
Furthermore, rising investments in research and development activities involving micro balloon catheters are expected to boost demand for this product. One of the major drivers of micro balloon catheter market shares is the use of micro balloon catheters in cardiac catheterization laboratories.
Furthermore, rising disposable income and rising healthcare spending are propelling the micro balloon catheter market forward. Several governments have reimbursement policies in place to assist people suffering from cardiovascular diseases. The demand for micro balloon catheters is driven by these factors.
Awareness campaign by NGO about awareness of cardiac diseases is a low driving factor for the micro balloon catheter market. New innovative technologies and The increasing number of balloon catheter product launches has fueled the growth of the micro-balloon catheter market. Manufacturing companies that produce low-cost micro balloon catheters may provide an opportunity for this market to grow in low-income countries.
Contact our Market Research Specialist@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-5860
However, the costs of angioplasty procedures are extremely high, and the risk of artery collapse and infection associated with balloon catheterization is expected to impede sales of micro balloon catheters, limiting market growth for micro balloon catheters.
Furthermore, stringent regulatory authorities and alternative options such as bypass surgery are likely to stymie the growth of the overall micro balloon catheter market.
Who are the key players in the Micro Balloon Catheters Market?
The key players in the micro balloon catheters market are: Terumo Corporation, Cook Medical, Piolax Medical Devices Inc., Boston Scientific Corporation, Stryker Corporation, Medtronic plc., Edward Life Sciences Corporation, MicroPort Scientific Corporation, B. Braun Melsungen AG.
What are the Key Trends and Notable Developments in the Micro Balloon Catheters Market?
Some of the notable developments in the micro balloon catheter market are:
- After receiving the CE (Conformité Européenne) mark, Medtronic will launch the next-generation drug-coated balloon catheter ‘Prevail’ for the treatment of coronary artery disease in Europe in July 2021.
- Neurescue received 510k clearance from the US Food and Drug Administration in June 2021 for their NEURESCUE® device, dubbed “the world’s first intelligent balloon catheter” and designed for temporary occlusion of large vessels such as the aorta.
- Alvimedica received CE mark approval for their Fluydo NC, a new PTCA NON-COMPLIANT Balloon Catheter, in March 2021. The device includes a new Non-Compliant Balloon designed to efficiently dilate the hardest lesions found in the most difficult and challenging coronary lesions.
Request Customization of Report@ https://www.futuremarketinsights.com/customization-available/rep-gb-5860
Key Segments
By Indication:
- Coronary Artery Diseases
- Peripheral Vascular Disease
By End-Users:
- Public Hospitals & Private Hospitals
- Ambulatory Surgical Centres
- Cardiac Catheterisation Laboratories
By Balloon Type:
- High-Pressure Balloons
- Elastomeric Balloons
By Catheter Type:
- Over-The-Wire (OTW) Balloon Catheters
- Rapid Exchange (RX) Balloon Catheters
- Fixed-Wire (FW) Balloon Catheters
Click here to Buy Report@ https://www.futuremarketinsights.com/checkout/5860
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs